mar3104_424b4

 

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(4)
   
TO PROSPECTUS DATED MARCH 28, 2001 REGISTRATION NO. 333-37072

GENENTECH, INC.

SHARES OF COMMON STOCK

     This prospectus supplement relates to the sale by certain selling shareholders of our common stock, par value $.02 per share, that was originally delivered in exchange for Liquid Yield Option Notes due 2015 issued by Roche Holdings, Inc.

     This prospectus supplement should be read in conjunction with the prospectus dated March 28, 2001, which is to be delivered with this prospectus supplement. All capitalized terms used but not defined in the prospectus supplement shall have the meanings given them in the prospectus.

     The table below sets forth information as of the date hereof concerning beneficial ownership of the common stock of the selling shareholders as listed below. All information concerning beneficial ownership has been furnished by the selling shareholders.

      NAME NUMBER OF SHARES OF
COMMON STOCK

OWNED PRIOR TO

OFFERING
NUMBER OF
SHARES OFFERED
NUMBER OF SHARES OF
COMMON STOCK

OWNED AFTER THE

OFFERING
PERCENTAGE OF
COMMON STOCK

OUTSTANDING





   Credit Suisse First Boston 131,528 131,528 0 *
   Europe Limited      
         
   FHS Trading, LTD. 86,531 86,531 0 *
         
   Plexus Fund Limited 129,797 129,797 0 *
         
   KBC Financial Products 51,226 51,226 0 *
   (Cayman Islands) Ltd.        
         
   Maystone Continuum 38,938 38,938 0 *
   Master Fund, Ltd.        
         
   Mariner LDC 38,938 38,938 0 *
         
   Lydian Overseas Partners 349,244 349,244 0 *
   Master Fund LTD.        
         
   Dylan (IMA) LTD. 21,633 21,633 0 *
         
   Lydian Global 21,633 21,633 0 *
   Opportunities Master        
   Fund LTD.        
         
   Silverback Master, LTD. 708,517 708,517 0 *
         

       
* Less than 1%        






THE SECURITIES OFFERED HEREBY INVOLVE A HIGH DEGREE OF RISK. SEE
“RISK FACTORS” BEGINNING ON PAGE 3 OF THE PROSPECTUS.

THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
SECURITIES AND EXCHANGE COMMISSION NOR HAS THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED
UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.


The date of this Prospectus Supplement is April 1, 2004.